Skip to main content
Poltreg S.A. logo

Poltreg S.A. — Investor Relations & Filings

Ticker · PTG ISIN · PLPLTRG00038 LEI · 259400XSAJTERJ42VZ86 WAR Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2022-08-31 Audit Report / Informat…
Country PL Poland
Listing WAR PTG

About Poltreg S.A.

https://poltreg.com/

Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.

Recent filings

Filing Released Lang Actions
Raport biegłego rewidenta z przeglądu sprawozdania finansowego
Audit Report / Information Classification · 99% confidence The document is titled 'RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU' (Independent Auditor's Review Report) concerning the 'śródrocznego skróconego sprawozdania finansowego' (condensed interim financial statements) for the period ending 30.06.2022. This clearly indicates it is a report detailing the results of an audit or review of financial statements for a period shorter than a year. This aligns perfectly with the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinguishing it from the full Annual Report (10-K) or a mere Earnings Release (ER). H1 2022
2022-08-31 Polish
Sprawozdanie Zarządu z działalności za okres 6 miesięcy zakończony dnia 30 czerwca 2022 roku
Management Reports Classification · 99% confidence The document is titled "SPRAWOZDANIE ZARZĄDU Z DZIAŁALNOŚCI ZA OKRES OD 01.01.2022 DO 30.06.2022 ROKU" which translates to "MANAGEMENT BOARD REPORT ON ACTIVITIES FOR THE PERIOD FROM 01.01.2022 TO 30.06.2022". It contains a detailed table of contents covering financial data, management structure, business activity, risk factors, and management commentary on financial results (Section 3.6, 3.7, 3.13). This structure is characteristic of a comprehensive report covering a specific financial period, but it is not the full annual report (10-K). Since it covers a period shorter than a year (six months, January 1 to June 30), it fits the definition of an Interim/Quarterly Report (IR). The document also includes a statement from the Management Board regarding the financial statement (Section 4), confirming its nature as a formal periodic report.
2022-08-31 Polish
Sprawozdanie finansowe za okres 6 miesięcy zakończony dnia 30 czerwca 2022 roku
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ŚRÓDROCZNE SKRÓCONE SPRAWOZDANIE FINANSOWE' (Interim Condensed Financial Report) for the period 01.01.2022 to 30.06.2022. It contains comprehensive financial statements, including the statement of comprehensive income, statement of financial position, and detailed notes. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-31 Polish
Zawarcie umowy o wspólności praw do uzyskania patentu i o wspólności praw z patentu - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement by the Management Board (Zarząd) of PolTREG S.A. regarding the signing of a tripartite agreement concerning the protection, use of intellectual property rights, and commercialization of two inventions (improvements in regulatory T-cell production). This agreement details ownership shares (10% for the company) and commercialization rights related to patents. This subject matter—intellectual property rights, patent applications, and commercialization agreements—does not fit neatly into standard financial reports (10-K, IR, ER) or corporate governance documents (DEF 14A, CGR). It is a specific announcement about a significant business development involving IP and potential future revenue streams. Given the options, this type of announcement, which details a specific legal/business transaction outside of standard financing or share dealing, is best categorized as a general Regulatory Filing (RNS) or potentially related to Intellectual Property (IP). Since 'IP' is defined as 'Investor Presentation' in the provided list, and this is a formal regulatory disclosure about an IP agreement, 'RNS' (Regulatory Filings - general regulatory announcements and fallback category) is the most appropriate classification for this specific, non-standard corporate event disclosure.
2022-08-10 Polish
Zawiadomienie od TFI Allianz Polska S.A. o zmianie udziału w ogólnej liczbie głosów PolTREG S.A. - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is a notification from the Management Board (Zarząd) of PolTREG S.A. informing about a change in the level of engagement (shareholding/voting rights) of funds managed by TFI Allianz Polska S.A. The text explicitly cites Polish public offering laws (Ustawa o ofercie publicznej) regarding changes in significant share ownership (referencing articles like 69 and 87, which typically govern major shareholding notifications). This type of filing, detailing changes in ownership thresholds by institutional investors, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is a formal regulatory disclosure about shareholding changes, not a general regulatory filing (RNS) or a report itself.
2022-07-06 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zgromadzeniu PolTREG S.A. w dniu 24 czerwca 2022 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is in Polish and details the list of shareholders (akcjonariuszy) who held at least 5% of the votes during the Annual General Meeting (Zwyczajnym Walnym Zgromadzeniu Spółki - ZWZ) held on June 24, 2022. This content directly relates to the official results of shareholder voting at a general meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document is short and contains the results, not an announcement of results, so RPA/RNS is less specific.
2022-06-24 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.